Publications and communications of Valérie QUAEDVLIEG

CALMES, D., Graff, S., MAES, N., Frix, A.-N., THYS, M., BONHOMME, O., Berg, J., DEBRUCHE, M., GESTER, F., HENKET, M., PAULUS, V., DUYSINX, B., HEINEN, V., NGUYEN DANG, D., PAULUS, A., QUAEDVLIEG, V., VAILLANT, F., VAN CAUWENBERGE, H., MALAISE, M., ... SCHLEICH, F. (2021). Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection. Journal of Allergy and Clinical Immunology: In Practice, 9 (1), 160-169. doi:10.1016/j.jaip.2020.09.044

MANISE, M., SCHLEICH, F., QUAEDVLIEG, V., Moermans, C., HENKET, M., SELE, J., CORHAY, J.-L., & LOUIS, R. (2012). Disturbed Cytokine Production at the Systemic Level in Difficult-to-Control Atopic Asthma: Evidence for Raised Interleukin-4 and Decreased Interferon-gamma Release following Lipopolysaccharide Stimulation. International Archives of Allergy and Immunology, 158 (1), 1-8. doi:10.1159/000329858

Schleich, F., Seidel, L., Sele, J., Manise, M., Quaedvlieg, V., Michils, A., & Louis, R. (2010). Exhaled nitric oxide thresholds associated with a sputum eosinophil count >=3% in a cohort of unselected patients with asthma. Thorax, 65 (12), 1039-1044. doi:10.1136/thx.2009.124925

Quaedvlieg, V., Sele, J., Henket, M., & Louis, R. (2009). Association between asthma control and bronchial hyperresponsiveness and airways inflammation: a cross-sectional study in daily practice. Clinical and Experimental Allergy, 39, 1822-1829. doi:10.1111/j.1365-2222.2009.03332.x

Quaedvlieg, V., Henket, M., Sele, J., & Louis, R. (January 2006). Cytokine production from sputum cells in eosinophilic versus non-eosinophilic asthmatics. Clinical and Experimental Immunology, 143 (1), 161-166. doi:10.1111/j.1365-2249.2005.02968.x

Quaedvlieg, V., Duysinx, B., Ghaye, B., & Bartsch, P. (2004). Le cas clinique du mois: Clarte pulmonaire unilaterale. Revue Médicale de Liège, 59 (12), 691-4.

Barthelemy, N., Bosquee, L., & Quaedvlieg, V. (August 2003). Phase II trial exploring gemcitabine and cisplatin as treatment of patients with non-small cell lung cancer (NSCLC) and inoperable brain metastases. Lung Cancer, 41 (supp2), 145.